Matches in Nanopublications for { ?s ?p "[Staining of MLH1, PARP1, XPF, and PAR was associated with recurrence-free survival, and staining of PARP1 and FANCD2 was associated with overall survival on multivariable analysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP210731.RAAqaPFzSUcFNAnO8zv8ExdQaSrmIGoHQfoI7gN-3rAjo130_assertion description "[Staining of MLH1, PARP1, XPF, and PAR was associated with recurrence-free survival, and staining of PARP1 and FANCD2 was associated with overall survival on multivariable analysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP210731.RAAqaPFzSUcFNAnO8zv8ExdQaSrmIGoHQfoI7gN-3rAjo130_provenance.
- NP605909.RA84SodhG9mHqbSKStRO1urJmJbwit0X9EJcQ2IwGsxYA130_assertion description "[Staining of MLH1, PARP1, XPF, and PAR was associated with recurrence-free survival, and staining of PARP1 and FANCD2 was associated with overall survival on multivariable analysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP605909.RA84SodhG9mHqbSKStRO1urJmJbwit0X9EJcQ2IwGsxYA130_provenance.
- NP382610.RAfDaDjrRUUrGnZCjM5K-AnUnudwuEf8DcVZlNUZMhZtM130_assertion description "[Staining of MLH1, PARP1, XPF, and PAR was associated with recurrence-free survival, and staining of PARP1 and FANCD2 was associated with overall survival on multivariable analysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP382610.RAfDaDjrRUUrGnZCjM5K-AnUnudwuEf8DcVZlNUZMhZtM130_provenance.
- NP741274.RAwlDyCLqzewsQ5b5F7Kk15ibneBIhiYcZEachniR5EBI130_assertion description "[Staining of MLH1, PARP1, XPF, and PAR was associated with recurrence-free survival, and staining of PARP1 and FANCD2 was associated with overall survival on multivariable analysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP741274.RAwlDyCLqzewsQ5b5F7Kk15ibneBIhiYcZEachniR5EBI130_provenance.
- NP809133.RAc7UoLjYB8SDnUSR2dHre5dyO-71xyTyiovXuQMgLb6Y130_assertion description "[Staining of MLH1, PARP1, XPF, and PAR was associated with recurrence-free survival, and staining of PARP1 and FANCD2 was associated with overall survival on multivariable analysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP809133.RAc7UoLjYB8SDnUSR2dHre5dyO-71xyTyiovXuQMgLb6Y130_provenance.
- NP640387.RAGPalQ5e96RKroez5hpHQSaWpbO7xpIq5mLCTubJ1ghk130_assertion description "[Staining of MLH1, PARP1, XPF, and PAR was associated with recurrence-free survival, and staining of PARP1 and FANCD2 was associated with overall survival on multivariable analysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP640387.RAGPalQ5e96RKroez5hpHQSaWpbO7xpIq5mLCTubJ1ghk130_provenance.
- NP937259.RAOVAfUhLhYHYUUEPtf1K7DqVeCP9WhVsUkSPny2ByHLE130_assertion description "[Staining of MLH1, PARP1, XPF, and PAR was associated with recurrence-free survival, and staining of PARP1 and FANCD2 was associated with overall survival on multivariable analysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP937259.RAOVAfUhLhYHYUUEPtf1K7DqVeCP9WhVsUkSPny2ByHLE130_provenance.
- NP225446.RA6FoGK4-Dzpb6IFuJt0wwRZfmr96zUqGbBYHxgaN6LFA130_assertion description "[Staining of MLH1, PARP1, XPF, and PAR was associated with recurrence-free survival, and staining of PARP1 and FANCD2 was associated with overall survival on multivariable analysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP225446.RA6FoGK4-Dzpb6IFuJt0wwRZfmr96zUqGbBYHxgaN6LFA130_provenance.
- NP393665.RAJsK_NtJ76j2mRspjMOOPryKcSY9QoScW6MpukllW91Q130_assertion description "[Staining of MLH1, PARP1, XPF, and PAR was associated with recurrence-free survival, and staining of PARP1 and FANCD2 was associated with overall survival on multivariable analysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP393665.RAJsK_NtJ76j2mRspjMOOPryKcSY9QoScW6MpukllW91Q130_provenance.
- NP855529.RA0JX7_G1Q_3demiHmgyO1JOXKrl6hAody1jWHLn6SpzY130_assertion description "[Staining of MLH1, PARP1, XPF, and PAR was associated with recurrence-free survival, and staining of PARP1 and FANCD2 was associated with overall survival on multivariable analysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP855529.RA0JX7_G1Q_3demiHmgyO1JOXKrl6hAody1jWHLn6SpzY130_provenance.